<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B06DBF11-FCBF-430E-AD9A-D0AE23BFFF60"><gtr:id>B06DBF11-FCBF-430E-AD9A-D0AE23BFFF60</gtr:id><gtr:name>Kwame Nkruma University of Science &amp; Tec</gtr:name><gtr:address><gtr:line1>KNUST</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89194876-5CDA-41E5-8C0F-30A57B260DA2"><gtr:id>89194876-5CDA-41E5-8C0F-30A57B260DA2</gtr:id><gtr:name>Kintampo Health Research Centre</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:department>Epidemiology and Population Health</gtr:department><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B06DBF11-FCBF-430E-AD9A-D0AE23BFFF60"><gtr:id>B06DBF11-FCBF-430E-AD9A-D0AE23BFFF60</gtr:id><gtr:name>Kwame Nkruma University of Science &amp; Tec</gtr:name><gtr:address><gtr:line1>KNUST</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89194876-5CDA-41E5-8C0F-30A57B260DA2"><gtr:id>89194876-5CDA-41E5-8C0F-30A57B260DA2</gtr:id><gtr:name>Kintampo Health Research Centre</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6FB146A7-6229-43ED-B06C-3B16EBD0FC68"><gtr:id>6FB146A7-6229-43ED-B06C-3B16EBD0FC68</gtr:id><gtr:firstName>Matthew</gtr:firstName><gtr:otherNames>Edward</gtr:otherNames><gtr:surname>Cairns</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/02FA8D21-6C94-485E-93E5-528E4027A43D"><gtr:id>02FA8D21-6C94-485E-93E5-528E4027A43D</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Milligan</gtr:surname><gtr:orcidId>0000-0003-3430-3395</gtr:orcidId><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FJ012394%2F1"><gtr:id>FBA0C112-931D-4216-AA2C-7FCA0CA16BA0</gtr:id><gtr:title>Maximising the impact of chemoprevention on the malaria burden in children in areas of seasonal transmission</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>MR/J012394/1</gtr:grantReference><gtr:abstractText>Malaria is a parasitic disease transmitted by mosquitoes that kills approximately 850,000 people every year, mostly children under five years of age living in sub-Saharan Africa. Prevention of malaria is key to achieving Millennium Development Goals. 
The epidemiology or disease pattern of malaria varies widely across Africa, both in terms of intensity (the number of infections individuals are exposed to), and seasonality (how the pattern of risk varies over the course of the year).
In areas of Africa where malaria is only a problem during a short rainy season, monthly courses of antimalarial drugs can prevent malaria in children very effectively. This approach, called seasonal malaria chemoprevention (SMC), may also be useful in places where malaria is transmitted for longer each year. However, the impact in such areas is not well understood.
Another form of prevention that would be easier for African countries to put into practice would be to treat malaria patients with long-lasting artemisinin combination therapies (LACTs), which prevent further malaria infections for several weeks. Malaria does not affect all children equally: a fraction of children repeatedly experience malaria, while other children remain healthy. Repeated malaria leads to severe anaemia, an important cause of death in areas where malaria is endemic. 
LACTs would prevent some repeated malaria attacks, and may be a simple and effective way to target limited resources at the individuals who most need protection. This may be particularly beneficial in areas with seasonal malaria transmission because repeated malaria attacks are likely to occur close together in time. In such areas, LACTs could help ensure that a child's first attack each year is their last.
Dr Matthew Cairns, an epidemiologist based at the London School of Hygiene &amp;amp; Tropical Medicine, will use a multi-disciplinary approach to investigate these issues.
Studies of malaria conducted in West Africa will provide data on the epidemiology of malaria in different areas. Data will be analysed to quantify the fraction of the total malaria and anaemia burden that occurs soon after a previous malaria attack, and which might therefore be prevented by replacing standard antimalarials with LACTs. This analysis will also determine the situations in which malaria is most unevenly focused on a small sub-group of children, and identify characteristics associated with high risk. This could lead to changes in which antimalarials are recommended as policy in some parts of Africa. 
A mathematical model developed by Dr Cairns will be extended to determine the impact of LACTs and SMC in a range of areas, using a range of assumptions about the effectiveness of drugs and the use of treatment by different children. The model will also allow exploration of the impact of combining these two interventions, which might be very expensive to do in a clinical trial. If the predicted impact of SMC is sufficient, this could lead to expansion of the area where SMC is deployed. Data from a clinical trial in Ghana investigating these two forms of prevention (arranged outside the fellowship), will be analysed to determine the real-life impact of these interventions, and help improve the accuracy of the model predictions.
Computer based simulations including rainfall and other climatic data will then be used to identify the geographical areas where SMC and LACTs are likely to be useful, and their potential impact on disease and on transmission of malaria. Maps will be produced showing results at sub-country level. 
Results of the research will help policy makers at the World Health Organisation and in malaria-endemic countries to make decisions on the recommended treatment for malaria, and to plan and prioritise where to deploy these two forms of malaria prevention. Both interventions could have an important impact on the health of African children within the next five years.</gtr:abstractText><gtr:technicalSummary>Aims and Objectives
Understand where replacing standard antimalarials with LACTs would be useful by quantifying the burden of repeated malaria and the heterogeneity in malaria risk in different epidemiological settings. 
Evaluate the potential for extended SMC and LACT in different epidemiological situations using a mathematical model and data from a clinical trial of SMC and LACT. 
Use a spatial modelling framework to determine the geographical areas where SMC and/or LACTs are likely to be advantageous, estimate the population at risk and the public health impact.

Methodology
Statistical models will be fitted to data from clinical trials to quantify dispersion in malaria incidence, and frailty models used to explore event dependence. The burden of repeat malaria will be determined and factors associated with high risk will be identified. A compartmental mathematical model of SMC and treatment of malaria will be fitted to trial data and extended to include multiple exposure/susceptibility strata, variable treatment access, and correlation of access with exposure. Sensitivity analyses will indicate the range in impact. Receiver-operating characteristic analysis will identify climatic predictors of suitable epidemiology for SMC and LACT. Areas will be mapped using high resolution climatic data, the populations at risk estimated using spatial population data, and the malaria burden estimated using published methods. The fitted compartmental model will be incorporated into an individual-based simulation to allow impact, effect on transmission, and effect of other control tools to be explored.

Scientific opportunities
Understanding heterogeneity in malaria risk is important for predicting the impact of all interventions accurately. The research may establish LACTs as a novel form of chemoprevention. 

Medical opportunities
The research has direct implications for policy changes that could reduce morbidity and death from malaria among African children.</gtr:technicalSummary><gtr:potentialImpactText>The research aims to identify the areas where two forms of drug-based prevention of malaria would be appropriate and estimate their impact, informing policy decisions on the following issues:

1) Changes in antimalarial treatment policy from recommendation of any artemisinin combination therapy (ACT), to a specific recommendation of long-acting ACTs (LACTs) such as dihydroartemisinin-piperaquine. This fellowship will be the first research undertaken to investigate this issue. A priori this is expected to be most appropriate in countries with seasonal malaria transmission. Research outputs will affect antimalarial treatment policy formally recommended by WHO, and drugs adopted in practice by National Malaria Control Programmes (NMCPs) in Africa.

2) Expansion of the area where seasonal malaria chemoprevention (SMC) is recommended from the current area of highly seasonal transmission only, to include seasonal areas with more months of malaria transmission. The research output may change policy regarding the area in which SMC is recommended to include a wider area, covering large highly populated areas of Africa with a high malaria burden (e.g. Ghana, Nigeria, others).

Specific beneficiaries
African children living in areas where policy is changed will benefit from improved health, specifically, fewer attacks of malaria and prevention of consequences of repeated malaria (severe anaemia and mortality). Children living in rural areas are likely to bear the greatest burden of repeat malaria; these approaches may help reduce health inequalities. 
Parents of African children will benefit from reduced impact of malaria on lives and livelihood (in seasonal areas, the peak in malaria and agricultural workload coincide), and lower financial and opportunity costs of repeated healthcare visits with their children. 
Public hospitals and health centres in malaria endemic areas will benefit from a reduced burden of malaria, particularly during the transmission peak, when capacity can be overwhelmed by paediatric malaria. Reductions in severe malaria and anaemia are likely to result in reduced transfusions and other resources needed for inpatients.
Policy makers in African Countries and NMCP managers. Outputs from the modelling will indicate, at sub-country level, which areas would benefit from these interventions and what the impact would be. A decision-making tool will be produced, enabling informed planning of where to deploy or prioritise deployment of SMC or LACTs.
Global health policy makers (WHO): Reduction in the malaria burden is essential to achieving Millennium Development Goals. Recommendation of first-line antimalarials are periodically changed to reflect changes in drug resistance, etc. Changing antimalarials used for treatment in seasonal transmission areas on the basis that they would be more effective is novel, but would be a simple policy change and one that could have an immediate and important impact.
Manufacturers of long-acting antimalarials may profit in areas where this becomes a recommended policy. However, I have no contact with such companies, nor any vested interest in this impact. 

Time scales 
Changing treatment policy could be implemented relatively rapidly. Allowing for dissemination of results, impact within 3-5 years is possible since the drugs needed are already licensed and approved for treatment of malaria in children. SMC will be recommended in 2012 in some countries in the Sahel, extension to a wider area is possible, but may depend on successful deployment in highly seasonal areas first to establish feasibility. Children involved in the clinical trial in Ghana arranged outside the context of the fellowship will benefit as soon as results are available, because community based delivery of antimalarials in the district is ongoing, and the drug used could be changed. Skills developed by the fellow working on the project will be applicable in future research (see Career Intentions).</gtr:potentialImpactText><gtr:fund><gtr:end>2015-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>281751</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC Centre for Outbreak Analysis and Modelling (Imperial College London)</gtr:description><gtr:id>0F9F0CA8-AE32-4105-9887-76A994C47824</gtr:id><gtr:impact>A number of papers have been published as listed elsewhere in this submission
Work carried out as part of this collaboration was used by the WHO in making their policy recommendation on seasonal malaria chemoprevention in 2012, in developing field guidelines for SMC, and in guiding implementation of SMC. Current work is being used to address a number of important practical questions related to SMC.</gtr:impact><gtr:outcomeId>56d6f8690bde95.51582814-1</gtr:outcomeId><gtr:partnerContribution>Several members of the group have contributed their expertise on mathematical modelling, as well as providing informal training in R and other software packages. 
I received formal training in Spatial Epidemiology as part of an MSc Epidemiology course run at ICL (in early 2014).</gtr:partnerContribution><gtr:piContribution>I have collaborated with a number of members of the group on studies of malaria modelling, and malaria epidemiology. I have also provided access to data from field studies to support the work of modellers in the group.
I am now an Honourary Lecturer at ICL as a result of this collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kintampo Health Research Centre</gtr:collaboratingOrganisation><gtr:country>Ghana, Republic of</gtr:country><gtr:description>Collaboration with Kintampo Health Research Centre, Kintampo, Ghana</gtr:description><gtr:id>D23F225E-2FBD-4AD7-8E71-D7CDCFEB895E</gtr:id><gtr:impact>Several publications on malaria epidemiology have now been published as a result of this collaboration</gtr:impact><gtr:outcomeId>56d6f6cb40add6.42086274-1</gtr:outcomeId><gtr:partnerContribution>Dr Asante and Dr Owusu-Agyei have provided access to data collected by KHRC, and expertise on malaria epidemiology in Ghana.</gtr:partnerContribution><gtr:piContribution>I contributed to PhD supervision of Dr KP Asante, and now collaborate with him on a number of malaria epidemiology projects</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kwame Nkrumah University of Science and Technology (KNUST)</gtr:collaboratingOrganisation><gtr:country>Ghana, Republic of</gtr:country><gtr:department>School of Public Health</gtr:department><gtr:description>Collaboration with Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana</gtr:description><gtr:id>AF7BEE6A-8B04-4CAE-871B-B8DEA03CCBB3</gtr:id><gtr:impact>A number of papers on malaria in pregnancy, and seasonal malaria chemoprevention in children have been published (see publication list).

Main disciplines are clinical trials, epidemiology, statistics.

The work on malaria in pregnancy was discussed at a meeting of the WHO Evidence Review Group in July 2015.</gtr:impact><gtr:outcomeId>56d6ee580245d1.08787884-1</gtr:outcomeId><gtr:partnerContribution>The study team at KNUST were responsible for carrying out the field study, data collection, community engagement/sensitisation, dissemination of study results to community leaders, and contributed to paper writing, and presentation at conferences.

The co-PI based in Ghana was jointly responsible for ethical approval, development of the protocol, and was responsible for oversight of trial staff.</gtr:partnerContribution><gtr:piContribution>I was a co-PI on a trial of seasonal malaria chemoprevention carried out in the Ashanti Region of Ghana. I was responsible for design of the study, writing of the protocol, submission for ethical approval, overseeing data management (blind to treatment allocation), drafting of the analysis plan, carrying out the analysis, writing the manuscript, submission of the paper for publication, and presentation at conferences.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>WHO Global Malaria Program</gtr:description><gtr:id>C48EAE56-D104-477B-8D80-972B6B492B80</gtr:id><gtr:impact>A number of publications as listed elsewhere in this submission. 
Two policy decisions on measures for malaria control on seasonal malaria chemoprevention in children, and on intermittent screening and treatment of malaria in pregnancy.</gtr:impact><gtr:outcomeId>56d6fa976238e2.77387705-1</gtr:outcomeId><gtr:partnerContribution>Input on aims of fellowship before and during the fellowship (in terms of focus, outputs, etc.). More recently discussions on future policy applications of work undertaken during the fellowship.</gtr:partnerContribution><gtr:piContribution>Member of the Evidence Review Group that considered the evidence for intermittent screening and treatment of malaria in pregnancy (ISTp) in July 2015. 

Presented work on long-acting artemisinin-based combination therapies (LACTs) undertaken during Population Health Scientist Fellowship as a WHO Technical Seminar in January 2016.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Liverpool School of Tropical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Liverpool School of tropical medicine on malaria in pregnancy</gtr:description><gtr:id>8C201A23-3049-448E-BA75-B4973528B180</gtr:id><gtr:impact>publications on malaria in pregnancy, as well as evidence submitted to policy makers, as described in other sections of the output.</gtr:impact><gtr:outcomeId>56d71350215917.00478487-1</gtr:outcomeId><gtr:partnerContribution>Provided expertise on malaria in pregnancy as related to intermittent screening and treatment, support in developing work for the WHO evidence review group, and other useful input to work on malaria in pregnancy/chemoprevention more generally.</gtr:partnerContribution><gtr:piContribution>Contributed statistical/epidemiological input as well as input as a mathematical modeller to working group on intermittent screening for malaria in pregnancy malaria in pregnancy. Ongoing work to model alternative interventions for malaria in pregnancy, as well as understanding how/where existing interventions would be best deployed</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Talk at MSF on chemoprevention (July 2016)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6018D959-13CE-4E3C-BA10-453D3834D3B2</gtr:id><gtr:impact>Presented on various malaria chemoprevention strategies to MSF programme staff developing malaria control packages.</gtr:impact><gtr:outcomeId>58b56e94cf64d0.30513650</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation on Malaria Chemoprevention to Medecins Sans Frontieres</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A66519BA-92BB-4337-988F-E7A167F563F3</gtr:id><gtr:impact>I gave a 45-minute lecture to students on the MSF course Global Health and Humanitarian Medicine, followed by a question and answer session.

This was later made available online to students following the MSF course remotely.</gtr:impact><gtr:outcomeId>56d70de6ae4954.56613361</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to policy-makers at WHO global malaria programme</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>12DA8944-91B0-414E-9D09-61FE91D7F7A6</gtr:id><gtr:impact>I was invited to present work from my MRC-funded Population health scientist Fellowship at the WHO global malaria programme in January 2016</gtr:impact><gtr:outcomeId>56d70e67369c13.65354779</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sir Halley Stewart Trust</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Sir Halley Stewart Trust</gtr:fundingOrg><gtr:id>CE1208EA-8F28-4C08-9D1D-CBE0D9D77428</gtr:id><gtr:outcomeId>56d70c8f580f98.34606528</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Use of modelling / population estimates to support implementation and scale-up of seasonal malaria chemoprevention</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>1993FEF1-A103-4A82-9678-3DD0B9E40526</gtr:id><gtr:impact>Maps and estimates of populations living in areas of seasonal malaria transmission produced during this fellowship have been used to guide implementation and scale up of seasonal malaria chemoprevention in the Sahel and sub- Sahel regions of Africa. This role is ongoing as SMC is expanded in this region of Africa</gtr:impact><gtr:outcomeId>56d714af5c7925.25803240</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Submission / Presentation to WHO Evidence Review Group (ERG) on Intermittent Screening and Treatment of malaria in Pregnancy (ISTp)</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>1F4DD6F6-52E0-4A19-A0B3-A9D669054653</gtr:id><gtr:outcomeId>56d6fcd72933f2.20104178</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Referenced in WHO guidelines on Seasonal Malaria Chemoprevention</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:guidelineTitle>Seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in children: A field guide</gtr:guidelineTitle><gtr:id>E267F7A9-1DBA-478F-A16E-5D51395CEC03</gtr:id><gtr:impact>Our work on mapping areas where seasonal malaria chemoprevention (SMC) would be appropriate was used to guide the initial policy recommendation on SMC in 2012. This work was cited in the WHO field guidelines on SMC, and the maps and ongoing work within the fellowship are currently (2014-15) being used to guide the implementation of SMC in the areas where it would be most effective.</gtr:impact><gtr:outcomeId>g9aTRNDU3hP</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Seasonal malaria chemoprevention is currently WHO-recommended policy for the prevention of malaria in children in areas with a short rainy season. This study evaluated SMC in an area of extended seasonal transmission, representative of large and highly populated areas of West Africa. Current consideration is being given to adapting SMC to allow it to be used in areas with a longer rainy season, results from this trial will help support those decisions.</gtr:description><gtr:id>AB8C9E54-D916-430E-9C64-D28A07C1310B</gtr:id><gtr:impact>In addition to the results on effectiveness, results related to intervention coverage and qualitative research on acceptability are being used to refine use of SMC in similar areas.</gtr:impact><gtr:outcomeId>56d7164c5255e1.23411300</gtr:outcomeId><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Clinical trial of seasonal malaria chemoprevention in areas of extended seasonal transmission (rainy season longer than six months)</gtr:title><gtr:type>Preventative Intervention - Nutrition and Chemoprevention</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>61D769C0-52A0-4E97-AF88-9D653BB2D583</gtr:id><gtr:title>Non-malaria fevers in a high malaria endemic area of Ghana.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08b4f51800ae29f0d5ca373c6993b0f0"><gtr:id>08b4f51800ae29f0d5ca373c6993b0f0</gtr:id><gtr:otherNames>Asante KP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>58b56f55244859.27447791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E535150-B281-474B-A02F-D74C77C78F7A</gtr:id><gtr:title>The risk of malaria in Ghanaian infants born to women managed in pregnancy with intermittent screening and treatment for malaria or intermittent preventive treatment with sulfadoxine/pyrimethamine.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b252237a355487ac832d29bbb51c0c8"><gtr:id>6b252237a355487ac832d29bbb51c0c8</gtr:id><gtr:otherNames>Awine T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>56d6e29384d742.74502039</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8F563D7-14C5-491F-B819-620F195F91B0</gtr:id><gtr:title>Evaluation of the impact of disease prevention measures: a methodological note on defining incidence rates.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6bb25f55d04d054716ffbe00ff191b"><gtr:id>ad6bb25f55d04d054716ffbe00ff191b</gtr:id><gtr:otherNames>Cheung YB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>5aa7a8ec169152.43538630</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA27A924-BEC7-4428-A9E9-17CC64486E38</gtr:id><gtr:title>Seasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan Africa.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f51342f6c7c83db2e5ba87a366a48f4a"><gtr:id>f51342f6c7c83db2e5ba87a366a48f4a</gtr:id><gtr:otherNames>Cairns ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>56d6dc16637891.05184957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52D1F7B4-2406-495C-9D0C-E7104AAB6786</gtr:id><gtr:title>Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39329687722d881b9b9a013c5c60f3e9"><gtr:id>39329687722d881b9b9a013c5c60f3e9</gtr:id><gtr:otherNames>Tagbor H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn><gtr:outcomeId>56d6dc16a6aa39.35916692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12C6CE80-0670-44CC-93BF-9BCA887139CB</gtr:id><gtr:title>Analysis of partial and complete protection in malaria cohort studies.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f51342f6c7c83db2e5ba87a366a48f4a"><gtr:id>f51342f6c7c83db2e5ba87a366a48f4a</gtr:id><gtr:otherNames>Cairns ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>pm_22892_22_24093726</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA4D9B90-71B5-4F66-B88D-B0EA2E1ECDD5</gtr:id><gtr:title>Facilitators and Barriers to Uptake of an Extended Seasonal Malaria Chemoprevention Programme in Ghana: A Qualitative Study of Caregivers and Community Health Workers.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28090770794070cb806246ea8e8188fd"><gtr:id>28090770794070cb806246ea8e8188fd</gtr:id><gtr:otherNames>Antwi GD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58b56f55d32461.06160720</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD7B8CCE-B513-4BE8-8111-E61CBF3E9427</gtr:id><gtr:title>Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5188ccdc7120f7d992477822f509e34"><gtr:id>f5188ccdc7120f7d992477822f509e34</gtr:id><gtr:otherNames>Ciss? B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>58b57cb316cc18.45829204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BB647DB-EEC2-4EEE-8CE8-DAA9E06A5D3F</gtr:id><gtr:title>Value of additional chemotherapy for malaria in pregnancy.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/256159da0b605caed5f2456efb37ed15"><gtr:id>256159da0b605caed5f2456efb37ed15</gtr:id><gtr:otherNames>Walker PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>56d6dc15524d07.07357409</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8141296F-FFE7-4837-B2FF-BF4EDF9127C3</gtr:id><gtr:title>Cluster randomized trial of text message reminders to retail staff in tanzanian drug shops dispensing artemether-lumefantrine: effect on dispenser knowledge and patient adherence.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e10fa1f86f42f71b79266358455ab78"><gtr:id>9e10fa1f86f42f71b79266358455ab78</gtr:id><gtr:otherNames>Bruxvoort K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn><gtr:outcomeId>5461f5f34850e5.86319745</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4557FC91-6D2F-4099-8BA2-5EDE04ADD3B9</gtr:id><gtr:title>Has Tanzania embraced the green leaf? Results from outlet and household surveys before and after implementation of the Affordable Medicines Facility-malaria.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dea1efc780d970792a1eed3415e1b32"><gtr:id>6dea1efc780d970792a1eed3415e1b32</gtr:id><gtr:otherNames>Thomson R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5461f5f31c3f45.39738943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BC9BCB2-2864-4208-800C-5007F17DFE62</gtr:id><gtr:title>Seasonal Dynamics of Malaria in Pregnancy in West Africa: Evidence for Carriage of Infections Acquired Before Pregnancy Until First Contact with Antenatal Care.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/218789110b451d395aeedd7e215adee6"><gtr:id>218789110b451d395aeedd7e215adee6</gtr:id><gtr:otherNames>Berry I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn><gtr:outcomeId>5aa7a8eb9bbb39.46247378</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45B435D0-1CBD-42A2-BF5F-1BD786B57BD8</gtr:id><gtr:title>A model of parity-dependent immunity to placental malaria.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/256159da0b605caed5f2456efb37ed15"><gtr:id>256159da0b605caed5f2456efb37ed15</gtr:id><gtr:otherNames>Walker PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_22892_22_23511473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4BCE131-AEF1-4339-A739-536E934DC1D4</gtr:id><gtr:title>Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/256159da0b605caed5f2456efb37ed15"><gtr:id>256159da0b605caed5f2456efb37ed15</gtr:id><gtr:otherNames>Walker PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>58c6b372745f31.46687105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BA7A7F5-6728-4682-8FC8-6729EEF0343E</gtr:id><gtr:title>Composite endpoints for malaria case-management: not simplifying the picture?</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f51342f6c7c83db2e5ba87a366a48f4a"><gtr:id>f51342f6c7c83db2e5ba87a366a48f4a</gtr:id><gtr:otherNames>Cairns ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>56d6dc1521c883.73920039</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4EA6AF7-778B-442C-BC1C-0994D05E26B7</gtr:id><gtr:title>Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3309c8580bce91100c1e5fca6490acd7"><gtr:id>3309c8580bce91100c1e5fca6490acd7</gtr:id><gtr:otherNames>Lo AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>pm_22892_22_23617576</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEFE0A3F-4D20-41FC-8D66-86F52290C507</gtr:id><gtr:title>Getting antimalarials on target: impact of national roll-out of malaria rapid diagnostic tests on health facility treatment in three regions of Tanzania.</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e10fa1f86f42f71b79266358455ab78"><gtr:id>9e10fa1f86f42f71b79266358455ab78</gtr:id><gtr:otherNames>Bruxvoort K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn><gtr:outcomeId>pm_22892_22_23937722</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D6BA360-C7E5-49DC-B0F0-2C1EA0B8E716</gtr:id><gtr:title>The Performance of a Rapid Diagnostic Test in Detecting Malaria Infection in Pregnant Women and the Impact of Missed Infections.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/567d4b6ee3c70dad438d62d84cf827f4"><gtr:id>567d4b6ee3c70dad438d62d84cf827f4</gtr:id><gtr:otherNames>Williams JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>56d6e6112cfda0.88053409</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5EEA4B9-48E5-49AE-929C-420CC1612B60</gtr:id><gtr:title>Analysis of Preventive Interventions for Malaria: Exploring Partial and Complete Protection and Total and Primary Intervention Effects.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dcc629b22436d387a13cba97aad4ab2"><gtr:id>4dcc629b22436d387a13cba97aad4ab2</gtr:id><gtr:otherNames>Cairns M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>5675e56736d6c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28A52B0D-A562-4806-8354-6E416610A51E</gtr:id><gtr:title>A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39329687722d881b9b9a013c5c60f3e9"><gtr:id>39329687722d881b9b9a013c5c60f3e9</gtr:id><gtr:otherNames>Tagbor H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d6dc162cdfd5.92054067</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75D06AB5-5B0E-4C8A-B9AF-6A19153B8289</gtr:id><gtr:title>Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy?</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e10fa1f86f42f71b79266358455ab78"><gtr:id>9e10fa1f86f42f71b79266358455ab78</gtr:id><gtr:otherNames>Bruxvoort K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>56d6dc157d4153.20219389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D277F142-7F60-4268-9329-CB0F9B62139A</gtr:id><gtr:title>Feasibility, safety and effectiveness of combining home based malaria management and seasonal malaria chemoprevention in children less than 10 years in Senegal: a cluster-randomised trial.</gtr:title><gtr:parentPublicationTitle>Transactions of the Royal Society of Tropical Medicine and Hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ff1912f45a1112a246b284ec83241a9"><gtr:id>1ff1912f45a1112a246b284ec83241a9</gtr:id><gtr:otherNames>Tine RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0035-9203</gtr:issn><gtr:outcomeId>5461f5f2e8b2c8.14378064</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7F24838-C77F-4CAC-8161-5A6691DA1C34</gtr:id><gtr:title>Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f24279cb762cddc202acc37d8f569f7"><gtr:id>4f24279cb762cddc202acc37d8f569f7</gtr:id><gtr:otherNames>Okell LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56d6dc14c33414.32435851</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC6CFDB9-7310-4B83-B2AB-03EAFD90F649</gtr:id><gtr:title>Placental malaria and the risk of malaria in infants in a high malaria transmission area in ghana: a prospective cohort study.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08b4f51800ae29f0d5ca373c6993b0f0"><gtr:id>08b4f51800ae29f0d5ca373c6993b0f0</gtr:id><gtr:otherNames>Asante KP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_22892_22_23908483</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>564C1180-8DE0-40A9-AAA5-75624ED849B0</gtr:id><gtr:title>Cost effectiveness of intermittent screening followed by treatment versus intermittent preventive treatment during pregnancy in West Africa: analysis and modelling of results from a non-inferiority trial.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4422fde598df1f26b6caa67126b273a"><gtr:id>e4422fde598df1f26b6caa67126b273a</gtr:id><gtr:otherNames>Fernandes S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>58b56f55a5b881.86724147</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B796B32-7076-462C-ABF2-21DB1043BEA0</gtr:id><gtr:title>Monthly malaria chemoprevention shows potential in an area of very high, perennial malaria transmission.</gtr:title><gtr:parentPublicationTitle>Evidence-based medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dcc629b22436d387a13cba97aad4ab2"><gtr:id>4dcc629b22436d387a13cba97aad4ab2</gtr:id><gtr:otherNames>Cairns M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1356-5524</gtr:issn><gtr:outcomeId>56d6dc15b5d891.11789226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59AA1867-5E82-4C46-8344-FA357AF229A8</gtr:id><gtr:title>Non-falciparum malaria infections in pregnant women in West Africa.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/491db2ad2037f9337d5af0a5ea667b45"><gtr:id>491db2ad2037f9337d5af0a5ea667b45</gtr:id><gtr:otherNames>Williams J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>56d6e293b56fa9.18199651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>190E3968-4161-4AFE-B547-85D5676F617F</gtr:id><gtr:title>Measuring Patient Adherence to Malaria Treatment: A Comparison of Results from Self-Report and a Customised Electronic Monitoring Device.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e10fa1f86f42f71b79266358455ab78"><gtr:id>9e10fa1f86f42f71b79266358455ab78</gtr:id><gtr:otherNames>Bruxvoort K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d6dc15e80376.25552733</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J012394/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>4F7FE31F-D266-4FE9-9BAB-3D21E9B789BA</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>3.3  Nutrition and chemoprevention</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>